Paediatrics

An ophthalmologic examination revealed bilateral anterior uveitis, though the patient had no ocular complaints at presentation

In a press release, the National Institute for Health and Care Excellence announced the first-ever approval for a mitochondrial disease treatment

Enhanced screenings and a unified registry could save vision and lives

The SYD-101 atropine formulation is licensed by Santen SA, based in Switzerland, from Sydnexis Inc, based in California

The researchers shared the first cohort study established in China that examines the relationship between secondhand smoke and early onset of myopia

The global prevalence of myopia has surged, and is expected to affect nearly 5 billion people by 2050

Dinah Zur, MD, shares insights from her International SPECTRALIS Symposium lecture

The 0.1 mg/ml atropine eye drop for paediatric myopia is licensed from Sydnexis, Inc.

The study found an increase in both refractive astigmatism and corneal astigmatism among a patient population of schoolchildren

Paediatric diagnoses of juvenile idiopathic intracranial hypertension, optic neuritis and Horner syndrome

According to a press release, Myatro XL is the first 0.05% atropine eye drop for paediatric myopia control.

Social media smartphone application–based interventions significantly improved adherence and parental knowledge among families of children with congenital ectopia lentis

Ophthalmologists report that dry eye syndrome, myopia progression and other ocular pathologies have increased, especially among paediatric patient groups

The study findings support the need to consider ophthalmologic monitoring in children with early-onset atopic dermatitis

How studies into myopia management can increase access to vision care

A pivotal phase 3 clinical trial found that SYD-101 met its 3-year primary endpoint for slowing paediatric myopia progression

The study assessed a large paediatric cohort for changes in spherical equivalent refraction, axial length, lens power and lens thickness

The study findings indicated that lifestyle changes associated with the COVID-19 pandemic were connected to an increase in childhood astigmatisms

SpliceBio continues to actively enroll patients in the ASTRA study and accompanying POLARIS trial

The UN Friends of Vision group meeting coincided with International Women's Day and the UN Commission on the Status of Women

The initiative marks the second annual ROP Awareness week, running from 24 February to 2 March, 2025

Researchers indicated that paediatric patients with Leber congenital amaurosis experienced improvements in vision

Children experienced sudden vision loss, visual field constriction, nyctalopia and dyschromatopsia following febrile illness

The study underscored a need for tailored approaches among specific patient populations

Intercontinental collaboration is key to unlocking ROP in our lifetime